Filed in archive
Diagnostics
, FDA Approvals
, Viruses and Viral Infection
by Gloria Gamat on January 7, 2008
The FDA has recently cleared for marketing, the very first test that can simultaneously detect and identify 12 specific respiratory viruses in one sample.
The said test, called the xTAG Respiratory Viral Panel (RVP) - (RVP) is a diagnostic test for the detection of multiple viral strains and subtypes designed to allow better decision-making in patient management and to limit the spread of infection.
Manufactured by the Toronto-based Luminex Molecular Diagnostics, the xTAG Respiratory Viral Panel can also identify various other viruses.
Read the FDA news to find out more details and the Luminex PR.
The said test, called the xTAG Respiratory Viral Panel (RVP) - (RVP) is a diagnostic test for the detection of multiple viral strains and subtypes designed to allow better decision-making in patient management and to limit the spread of infection.
Influenza A is the most severe form of influenza for humans, and has been the cause of major epidemics. The new panel is also the first test for human metapneumovirus (hMPV), newly identified in 2001.
The xTAG Respiratory Viral Panel amplifies viral genetic material found in secretions taken from the back of the throat in patients with possible respiratory tract infections. In the test, specific beads, or microspheres, bind to the amplified viral genetic material. The beads are then sorted so that the specific virus can be identified.
The xTAG panel is the first FDA-cleared test for infectious respiratory disease viruses that uses a multiplex platform, allowing several tests to be processed using the same sample.
Manufactured by the Toronto-based Luminex Molecular Diagnostics, the xTAG Respiratory Viral Panel can also identify various other viruses.
Read the FDA news to find out more details and the Luminex PR.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/109666
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for xTAG Respiratory Viral Panel, FDA-Cleared for Marketing:
|
Rating: 6.75 out of 4 vote(s) cast.
|
Response from:
Trusted.MD Network
An implantable electronic device that stimulates the diaphragm and allows certain spinal cord injury patients to breathe for at least four hours a day without a mechanical ventilator - NeuRx DPS RA/4 Respiratory Stimulation System - has been approved by t
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
